Company Overview - 加和国际控股有限公司 is a contract manufacturer based in Singapore, specializing in the production and sale of disposable medical devices and injection-molded plastic components, as well as providing mold-making services [2] - Established in 1981, the company has become a reliable contract manufacturer for major international healthcare and medical device companies [2] - The company's revenue is derived from two main segments: manufacturing and selling injection-molded plastic components for disposable medical devices, and providing mold-making services [2] Financial Performance - As of December 31, 2024, 加和国际控股 reported total revenue of 55.6565 million yuan, representing a year-on-year growth of 14.33% [1] - The company recorded a net profit attributable to shareholders of -14.0006 million yuan, showing a year-on-year increase of 61% [1] - The gross profit margin stood at 2.18%, while the debt-to-asset ratio was 75.71% [1] Market Position and Valuation - 加和国际控股's price-to-earnings (P/E) ratio is -7.04, ranking 87th in the industry, compared to the average P/E ratio of 0.66 and the median of 1.36 for the healthcare equipment and services sector [1] - Other companies in the same industry have varying P/E ratios, with 京玖康疗 at 0.38, 巨星医疗控股 at 0.4, 医汇集团 at 2.32, 环球医疗 at 5.31, and 瑞慈医疗 at 5.4 [1] Upcoming Events - The company is scheduled to disclose its mid-year report for the fiscal year 2025 on August 29, 2025 [3]
加和国际控股（08513.HK）8月18日收盘上涨13.85%，成交1.39万港元